scholarly article | Q13442814 |
P2093 | author name string | Cynthia Gates Goodyer | |
Samar Elzein | |||
P2860 | cites work | Human MicroRNA targets | Q21563637 |
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development | Q22000752 | ||
NIH Image to ImageJ: 25 years of image analysis | Q23319322 | ||
GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils | Q24291670 | ||
Expression of the hepatic specific V1 messenger ribonucleic acid of the human growth hormone receptor gene is regulated by hepatic nuclear factor (HNF)-4alpha2 and HNF-4alpha8 | Q24299936 | ||
Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism | Q24339618 | ||
Fast and effective prediction of microRNA/target duplexes | Q24537313 | ||
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals | Q24630840 | ||
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer | Q24632636 | ||
MiR-15a and miR-16-1 cluster functions in human leukemia | Q24647555 | ||
The microRNA.org resource: targets and expression | Q24650094 | ||
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma | Q24653676 | ||
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
Combinatorial microRNA target predictions | Q27860510 | ||
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer | Q28211530 | ||
Reduced accumulation of specific microRNAs in colorectal neoplasia | Q28211976 | ||
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives | Q28247489 | ||
DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1 | Q28251481 | ||
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia | Q28269786 | ||
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer | Q28271985 | ||
Chromosome mapping of the growth hormone receptor gene in man and mouse | Q28279247 | ||
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation | Q28280072 | ||
miR-129 regulates cell proliferation by downregulating Cdk6 expression | Q28280144 | ||
Posttranscriptional regulation of microRNA biogenesis in animals | Q28282519 | ||
Mechanisms of gene silencing by double-stranded RNA | Q28282560 | ||
The growth hormone receptor: mechanism of activation and clinical implications | Q28289018 | ||
A pancreatic islet-specific microRNA regulates insulin secretion | Q28292726 | ||
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | Q28297958 | ||
A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein | Q28305213 | ||
Growth hormone receptor is expressed in human breast cancer | Q28362049 | ||
MicroRNAs: history, biogenesis, and their evolving role in animal development and disease | Q28657834 | ||
Prediction of both conserved and nonconserved microRNA targets in animals. | Q45964956 | ||
Alternative processing of growth hormone receptor transcripts | Q46443252 | ||
Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver. | Q51027547 | ||
Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors. | Q51550379 | ||
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. | Q51958786 | ||
Developmental biology. Encountering microRNAs in cell fate signaling. | Q52033155 | ||
Organization and evolution of the human growth hormone receptor gene 5'-flanking region. | Q52136419 | ||
[Effect of rhGH on JAK2-STAT3 signal pathway after GHR was down-regulated by siRNA in gastric cancer cell]. | Q53104590 | ||
[Fine structure, expression and polymorphism of the human growth hormone receptor gene] | Q53846714 | ||
Growth hormone receptor expression in human colorectal cancer. | Q54697650 | ||
Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract | Q71683281 | ||
[Expression of growth hormone receptor in hepatocellular carcinoma and its significance] | Q73166355 | ||
Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas | Q74236499 | ||
Cellular expression of growth hormone and prolactin receptors in human breast disorders | Q74534960 | ||
Expression of growth hormone receptor in human prostatic carcinoma and hyperplasia | Q77314920 | ||
Growth hormone receptor expression is up-regulated during tumorigenesis of human colorectal cancer | Q80977416 | ||
[Growth hormone receptor expression in human colorectal cancer and its implication] | Q81225179 | ||
miRDB: a microRNA target prediction and functional annotation database with a wiki interface | Q28754510 | ||
Regulation of mRNA translation and stability by microRNAs | Q29547304 | ||
Small non-coding RNAs in animal development | Q29616776 | ||
Diurnal variation in growth hormone receptor messenger ribonucleic acid in liver and skeletal muscle of lit/+ and lit/lit mice | Q30435611 | ||
Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation | Q33316795 | ||
Transcriptional regulation of the human growth hormone receptor (hGHR) gene V2 promoter by transcriptional activators and repressor | Q33670512 | ||
STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease | Q33680286 | ||
Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene | Q34017894 | ||
Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma | Q34191041 | ||
Clock-controlled mir-142-3p can target its activator, Bmal1. | Q34408755 | ||
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. | Q34758345 | ||
Role of miR-142-3p in the post-transcriptional regulation of the clock gene Bmal1 in the mouse SCN. | Q34766364 | ||
Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer | Q34921140 | ||
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues | Q34997758 | ||
Coordinate microRNA-mediated regulation of protein complexes in prostate cancer | Q35082892 | ||
Endocrine control of body composition in infancy, childhood, and puberty | Q36029001 | ||
Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders | Q36577046 | ||
Growth hormone receptor expression in human primary gastric adenocarcinoma | Q36732884 | ||
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows | Q36953893 | ||
How growth hormone controls growth, obesity and sexual dimorphism | Q37026372 | ||
New insights into growth hormone receptor function and clinical implications | Q37064814 | ||
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells | Q37487108 | ||
To localize or not to localize: mRNA fate is in 3'UTR ends | Q37588945 | ||
Growth hormone and cancer: an update on progress. | Q38117566 | ||
Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression | Q38318287 | ||
The effects of recombinant human GH on promoting tumor growth depend on the expression of GH receptor in vivo | Q38331858 | ||
Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse | Q38428925 | ||
Human growth hormone receptor gene expression is regulated by Gfi-1/1b and GAGA cis-elements | Q39607471 | ||
Characterization of growth hormone receptor messenger ribonucleic acid variants in human adipocytes | Q40313342 | ||
Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice. | Q40453146 | ||
Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells | Q40545524 | ||
Co-expression of GH and GHR isoforms in prostate cancer cell lines | Q40639760 | ||
The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line | Q40797779 | ||
Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues | Q40860825 | ||
The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription | Q41263816 | ||
Expression and binding properties of two isoforms of the human growth hormone receptor | Q41565624 | ||
miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer | Q42051478 | ||
Variants of the 5'-untranslated sequence of human growth hormone receptor mRNA | Q42598367 | ||
Circadian oscillation of gene expression in murine calvarial bone. | Q42605243 | ||
Functional microRNA targets in protein coding sequences | Q42634002 | ||
Expression profile analysis reveals putative prostate cancer-related microRNAs | Q45831277 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 9 | |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 1448-1459 | |
P577 | publication date | 2014-07-29 | |
P1433 | published in | Molecular Endocrinology | Q3319475 |
P1476 | title | Regulation of human growth hormone receptor expression by microRNAs | |
P478 | volume | 28 |
Q62083307 | Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism |
Q92835211 | Effects of miR-129-3p on biological functions of prostate cancer cells through targeted regulation of Smad3 |
Q93012952 | Fetal malnutrition-induced catch up failure is caused by elevated levels of miR-322 in rats |
Q54110794 | Growth Hormone Receptor Mutations Related to Individual Dwarfism. |
Q33755171 | Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease. |
Q36276533 | How interacting pathways are regulated by miRNAs in breast cancer subtypes |
Q50417171 | MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. |
Q35684427 | Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells |
Q33829561 | Roles of differential expression of microRNA-21-3p and microRNA-433 in FSH regulation in rat anterior pituitary cells |
Search more.